Gender differences in the relation between tnterview-derived hostility scores and resting blood pressure

1996 ◽  
Vol 19 (2) ◽  
pp. 185-201 ◽  
Author(s):  
Karina Davidson ◽  
Peter Hall ◽  
Michael MacGregor
Keyword(s):  
Blood Pressure ◽  
Gender Differences ◽  
Resting Blood Pressure

Gender Differences in Pain Sensitivity and Resting Blood Pressure

2010 ◽  
Author(s):  
Suzanne G. Helfer ◽  
Ashley D. Bugeja ◽  
Sarah E. Jackson ◽  
Elizabeth Woltja
Keyword(s):  
Blood Pressure ◽  
Gender Differences ◽  
Pain Sensitivity ◽  
Resting Blood Pressure

System-Justifying Beliefs Moderate the Relationship Between Perceived Discrimination and Resting Blood Pressure

2011 ◽  
Vol 29 (3) ◽  
pp. 303-321 ◽  
Author(s):  
Dina Eliezer ◽  
Sarah S. M. Townsend ◽  
Pamela J. Sawyer ◽  
Brenda Major ◽  
Wendy Berry Mendes
Keyword(s):  
Blood Pressure ◽  
Perceived Discrimination ◽  
Resting Blood Pressure ◽  
The Relationship

Cynical hostility, anger, and resting blood pressure

1996 ◽  
Vol 40 (4) ◽  
pp. 359-368 ◽  
Author(s):  
John Spicer ◽  
Kerry Chamberlain
Keyword(s):  
Blood Pressure ◽  
Resting Blood Pressure ◽  
Cynical Hostility

scholarly journals Genomewide Linkage Scan of Resting Blood Pressure

Hypertension ◽  
2002 ◽  
Vol 39 (6) ◽  
pp. 1037-1043 ◽  
Author(s):  
Treva Rice ◽  
Tuomo Rankinen ◽  
Yvon C. Chagnon ◽  
Michael A. Province ◽  
Louis Pérusse ◽  
...  
Keyword(s):  
Blood Pressure ◽  
Genomewide Linkage ◽  
Resting Blood Pressure

Ambulatory blood pressure using 60 rather than 20-min intervals may better reflect the resting blood pressure

2021 ◽  
pp. 1-7
Author(s):  
Karol M. Dabrowski ◽  
Jakob Nyvad ◽  
Martin B. Thomsen ◽  
Jannik B. Bertelsen ◽  
Kent L. Christensen
Keyword(s):  
Blood Pressure ◽  
Ambulatory Blood Pressure ◽  
Resting Blood Pressure

Abstract P120: Omega-3 Fatty Acid Supplementation in Middle-Aged Adults Reduces Cardiometabolic Risk in Men but not Women

Circulation ◽  
2014 ◽  
Vol 129 (suppl_1) ◽  
Author(s):  
Claire Newlon ◽  
Matthew Muldoon ◽  
Susan Sereika ◽  
Dora Kuan
Keyword(s):  
Blood Pressure ◽  
Gender Differences ◽  
Fatty Acids ◽  
Fatty Acid ◽  
Cardiometabolic Risk ◽  
Acid Metabolism ◽  
Hdl Cholesterol ◽  
Omega 3 Fatty Acids ◽  
Omega 3 ◽  
Middle Aged Adults

Background: Greater consumption of omega-3 fatty acids has been associated with lower cardiovascular disease risk. Randomized controlled trials indicate direct, albeit small, beneficial effects of omega-3 fatty acids on plasma triglycerides and blood pressure, yet few studies have tested their impact on insulin resistance and the clustered risk factors comprising the metabolic syndrome. Hypothesis: Short-term supplementation with marine omega-3 polyunsaturated fatty acids, EPA (eicosapentaenoic acid) and DHA (docosahexaenoic acid) will improve aggregated cardiometabolic risk (CMR) in healthy middle-aged adults Methods: We conducted a double-blind, placebo-controlled, parallel group clinical trial. Subjects were 30-54 year-old adults free of atherosclerotic disease and diabetes whose intake of EPA and DHA totaled <300 mg/day. Each was randomly assigned to daily fish oil supplements (2g/day containing 1000 mg EPA and 400mg DHA) or matching soybean oil placebo for 18 weeks. Aggregate CMR at baseline and post-intervention was calculated as the standardized sum of standardized distributions of blood pressure, BMI, and fasting serum triglycerides, glucose, and HDL (reverse scored). Missing data due to dropouts (n=17) and outliers (1-6 per variable) were replaced by multivariate imputation. Outcome analyses were conducted with linear regressions of all randomized subjects based on intention-to-treat. Results: Participants were 272 healthy adult (57% (154 out of 272) women; 17% (47 out of 272) minority; mean age 42) Pittsburgh-area residents. At baseline, demographics, health parameters, physical activity and EPA and DHA consumption did not differ significantly between treatment groups. No overall treatment effect was found, whereas gender moderated the effects of treatment on CMR risk (gender, p=.001 and gender*treatment interaction term p=.011). In gender-specific analyses, supplementation lowered CMR risk relative to placebo in men(p=.036, effect size=.629, standard error (SE) =.282) but not women (p=.168, effect size .261, SE=.222). Of the individual CMR variables, only HDL-cholesterol in men revealed a significant improvement (p=.012). In men receiving placebo, HDL-cholesterol fell by 1.1 mg/dl, whereas in those receiving fish oil, HDL rose by 1.7 mg/dl. As has been noted in other samples, compared to women men had greater CMR and lower HDL-cholesterol. Conclusions: Increased intake of n-3 fatty acids over 4 months reduced CMR in healthy, mid-life men but not women. This finding may be due to poorer baseline CMR and HDL characteristic of men, or to gender differences in fatty acid metabolism. Further study of gender differences in cardiometabolic risk and fatty acid metabolism may lead to gender-tailored preventive interventions.

Sign in / Sign up

Export Citation Format

Share Document